David S. Morgan, M.D.

Associate Professor

david.morgan@vanderbilt.edu
Faculty Appointments
Associate Professor of Medicine
Education
M.D., Medicine , Vanderbilt University, Nashville, TennesseeB.A., English, Yale University, New Haven, Connecticut
Office Address
Vanderbilt University Medical Center
777 Preston Research Building
2220 Pierce Avenue
Nashville, TN 37232-6307
Research Description
.
Publications
Reddy NM, Greer JP, Morgan DS, Chen H, Park SI, Richards KL. A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma. Leukemia [print-electronic]. 2017 Jan; 31(1): 241-4. PMID: 27654851, PMCID: PMC5214342, PII: leu2016255, DOI: 10.1038/leu.2016.255, ISSN: 1476-5551.

Nguyen VT, Pophali PA, Tsai JP, Jagadeesh D, Dean RM, Pohlman B, Morgan DS, Greer JP, Smith MR, Hill BT, Reddy NM. Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning [letter]. Br. J. Haematol [print-electronic]. 2016 Jul 7/13/2016; PMID: 27409578, DOI: 10.1111/bjh.14236, ISSN: 1365-2141.

Huntington SF, Talbott MS, Greer JP, Morgan DS, Reddy N. Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy. Leuk. Lymphoma [print-electronic]. 2012 Aug; 53(8): 1461-8. PMID: 22260160, DOI: 10.3109/10428194.2012.658793, ISSN: 1029-2403.

Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp. Hematol [print-electronic]. 2012 Jun; 40(6): 431-5. PMID: 22269114, PMCID: PMC4067702, PII: S0301-472X(12)00016-1, DOI: 10.1016/j.exphem.2012.01.014, ISSN: 1873-2399.

Reddy N, Greer JP, Goodman S, Kassim A, Morgan DS, Chinratanalab W, Brandt S, Englehardt B, Oluwole O, Jagasia MH, Savani BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp. Hematol [print-electronic]. 2012 May; 40(5): 359-66. PMID: 22269117, PII: S0301-472X(12)00014-8, DOI: 10.1016/j.exphem.2012.01.012, ISSN: 1873-2399.

Reddy N, Abel TW, Jagasia M, Morgan D, Weaver K, Greer J. Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab. Leuk. Lymphoma. 2009 Mar; 50(3): 460-2. PMID: 19266387, PII: 909254836, DOI: 10.1080/10428190802695827, ISSN: 1029-2403.

Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, Engelhardt B, Goodman S, Greer J, Kassim A, Morgan D, Ruffner K, Schuening F. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol. Blood Marrow Transplant [print-electronic]. 2007 Oct; 13(10): 1207-15. PMID: 17889358, PII: S1083-8791(07)00338-2, DOI: 10.1016/j.bbmt.2007.07.001, ISSN: 1083-8791.

Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk. Lymphoma. 2007 Sep; 48(9): 1728-35. PMID: 17786708, PII: 781802102, DOI: 10.1080/10428190701534374, ISSN: 1042-8194.

Jagasia MH, Greer JP, Morgan DS, Mineishi S, Kassim AA, Ruffner KL, Chen H, Schuening FG. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. Bone Marrow Transplant. 2005 Jun; 35(12): 1165-9. PMID: 15880129, PII: 1704994, DOI: 10.1038/sj.bmt.1704994, ISSN: 0268-3369.

Jagasia M, Morgan D, Goodman S, Hamilton K, Kinney M, Shyr Y, Stein R, Zic J, Greer J. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leuk. Lymphoma. 2004 Nov; 45(11): 2261-7. PMID: 15512815, PII: VDJ562CRM6ENDF6H, DOI: 10.1080/10428190412331272749, ISSN: 1042-8194.

Lavely WC, Delbeke D, Greer JP, Morgan DS, Byrne DW, Price RR, Hallahan DE. FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003 Oct 10/1/2003; 57(2): 307-15. PMID: 12957239, PII: S0360301603005996, ISSN: 0360-3016.

Arrowsmith ER, Macon WR, Kinney MC, Stein RS, Goodman SA, Morgan DS, Flexner JM, Cousar JB, Jagasia MH, McCurley TL, Greer JP. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk. Lymphoma. 2003 Feb; 44(2): 241-9. PMID: 12688340, DOI: 10.1080/1042819021000030054, ISSN: 1042-8194.

Delbeke D, Martin WH, Morgan DS, Kinney MC, Feurer I, Kovalsky E, Arrowsmith T, Greer JP. 2-deoxy-2-[F-18]fluoro-D-glucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma. Mol Imaging Biol. 2002 Jan; 4(1): 105-14. PMID: 14538054, PII: S1095039701000589, ISSN: 1536-1632.

Stein RS, Wolff SN, Greer JP, Flexner JM, Goodman S, Jagasia M, Brandt SJ, Morgan DS, Arrowsmith E, McCurley TL. Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. Leuk. Lymphoma. 2001 Sep; 42(5): 913-22. PMID: 11697646, DOI: 10.3109/10428190109097710, ISSN: 1042-8194.

Vusirikala M, Wolff SN, Stein RS, Brandt SJ, Morgan DS, Greer JP, Schuening FG, Dummer JS, Goodman SA. Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis. Bone Marrow Transplant. 2001 Aug; 28(3): 265-70. PMID: 11535994, DOI: 10.1038/sj.bmt.1703129, ISSN: 0268-3369.

Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphoma. Leuk. Lymphoma. 2001 Mar; 41(1-2): 97-103. PMID: 11342361, PII: I308J001145, DOI: 10.3109/10428190109057958, ISSN: 1042-8194.

Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma. Leuk. Lymphoma. 2001 Feb; 40(5-6): 521-8. PMID: 11426525, DOI: 10.3109/10428190109097651, ISSN: 1042-8194.

Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma. Leukemia and Lymphoma. 2001; 40(5-6):((February)): 521-8.

Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphoma. Leukemia and Lymphoma. 2001; 41(1-2)((March)): 97-103.

Stein RS, Wolff SN, Greer JP, Flexner JM, Goodman S, Jagasia M, Brandt SJ, Morgan DS, Arrowsmith E, McCurley TL. Age and Cytogenetics as Predictors of Event Free Survival in Patients with Acute Non-Lymphocytic Leukemia Receiving High Dose Cytosine Arabinoside and Daunorubicin as Consolidation Chemotherapy. Leukemia and Lymphoma. 2001; 42(5)((February)): 913-22.

Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma. Bone Marrow Transplant. 2000 Feb; 25(3): 257-62. PMID: 10673696, DOI: 10.1038/sj.bmt.1702132, ISSN: 0268-3369.

Delbeke, Morgan DS, Kovalsky E, Dangleis K, Cerci R, Martin WH, Kinney MC, Greer JP. 18F-Fluorodeoxyglucose Imaging with Positron Emission Tomography for Initial Staging of Hodgkin¿s Disease and Lymphoma. Journal of Nuclear Medicine. 2000; 41(5)(Suppl.) Abstract: 1207.

Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin¿s Lymphoma. Bone Marrow Transplantation. 2000; 25(3)((February)): 257-62.

Delbeke D, Morgan DS, Kovalsky E, Dangleis K, Cerci R, Martin WH, Kinney MC, Greer JP. 18F-F1 Fluorodeoxyglucose Imaging With Positron Emission Tomography in the Follow-Up of Patients With Lymphoma. Journal of Nuclear Medicine. 2000; 41(5)(Suppl.): Abstract 276.

Delbeke, Morgan DS, Kovalsky E, Dangleis K, Cerci R, Martin WH, Kinney MC, Greer JP. 18F-Fluorodeoxyglucose Imaging with Positron Emission Tomography for Initial Staging of Hodgkin¿s Disease and Lymphoma. Journal of Nuclear Medicine. 2000; ((41(5)(Suppl.))): Abstract 1207.

Morgan DS, Simpson JF. Non-Hodgkin¿s Lymphoma of the Breast. Textbook of Uncommon Cancer. 1999.

Horwitz SM, Ranheim EA, Morgan DS, Horning SJ. Unified Approach to Post-Transplant Lymphoproliferative Disorder (PTLD): Improved Outcome and Analysis of Prognostic Factors. Blood. 1999; 94:10(Suppl. 1) Abstr 2295.

Morgan DS, Horning SJ. Indolent Lymphomas. Therapy of Hematopoietic Neoplasia. 1998.

Arrowsmith ER, Greer JP, Stein RS, Wolff SN, Goodman SA, Kallianpur AR, Flexner JM, Morgan DS, Kinney MC, Macon WR. Peripheral T-Cell Lymphomas (PTCL): A Clinicopathologic Study of 94 Unselected Patients Using the Revised European American Lymphoma (REAL) Classification. Proc Am Soc Clin Oncol. 1998; 17:A50.